Which has grown faster, FBIOP or STRO?

Over the past five years, STRO grew revenue faster — FBIOP at a 5.39% CAGR versus STRO at 19.13%.

Is FBIOP or STRO more profitable?

FBIOP runs the higher net margin — FBIOP at 163.32% versus STRO at -395.25%.

How have FBIOP and STRO total returns compared?

Over the past 5 years, FBIOP delivered 0.05% and STRO delivered -39.51% annualized total return. Past performance doesn't predict future results.

Fortress Biotech, Inc. (FBIOP) vs Sutro Biopharma, Inc. (STRO)

A side-by-side comparison of Fortress Biotech, Inc. and Sutro Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

FBIOP

Fortress Biotech, Inc.

$144M

$18.25HealthcareDelayed quote: Oct 6, 2026, 1:46 PM EDT

STRO

Sutro Biopharma, Inc.

$141M

$14.57HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — FBIOP vs STRO

growth of $100 · dividends reinvested · last 8y

FBIOP +90.3% (+8.4%/yr)STRO -90.0% (-25.1%/yr)FBIOP compounded faster over this window

Log scale — wide-divergence pair

FBIOP STRO

FBIOP vs STRO: by the numbers

•FBIOP is the larger company ($144M vs $141M market cap).
•FBIOP is profitable (163.32% net margin) while STRO runs a net loss (-395.25%).
•STRO grew revenue faster over the past five years (19.13% vs 5.39% CAGR).

Metrics side by side

Valuation

Metric	FBIOP	STRO
P/E ratio	6.80	N/A
Forward P/E	7.16	N/A
P/S ratio	2.10	3.09
P/B ratio	0.88	N/A
FCF yield	87.59%	N/A

Profitability

Metric	FBIOP	STRO
Gross margin	62.53%	97.20%
Operating margin	-111.00%	-102.41%
Net margin	163.32%	-395.25%
ROE	68.12%	N/A
ROIC	-10.85%	-100.04%

Growth (annualized)

Metric	FBIOP	STRO
Revenue CAGR (5Y)	5.39%	19.13%
Total return CAGR (5Y)	0.05%	-39.51%

Frequently asked

Which has grown faster, FBIOP or STRO?: Over the past five years, STRO grew revenue faster — FBIOP at a 5.39% CAGR versus STRO at 19.13%.
Is FBIOP or STRO more profitable?: FBIOP runs the higher net margin — FBIOP at 163.32% versus STRO at -395.25%.
How have FBIOP and STRO total returns compared?: Over the past 5 years, FBIOP delivered 0.05% and STRO delivered -39.51% annualized total return. Past performance doesn't predict future results.

Go deeper

Full FBIOP analysis Full STRO analysis Interactive comparison tool

Dig into the metrics

Fortress Biotech P/E ratio Fortress Biotech ROE Sutro Biopharma ROE Fortress Biotech operating margin Sutro Biopharma operating margin Fortress Biotech revenue growth Sutro Biopharma revenue growth Fortress Biotech free cash flow Sutro Biopharma free cash flow

Fortress Biotech & Sutro Biopharma appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.